ADAR1 Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management GP, LLC
Security
Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
IKT
Shares outstanding
128,205,929 shares
Disclosed Ownership
12,692,387 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 18:22:03 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 9.9% 12,523,371 0 12,523,371 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
ADAR1 Capital Management GP, LLC 9.9% 12,692,387 0 12,692,387 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 9.9% 12,523,371 0 12,523,371 /s/ Daniel Schneeberger Daniel Schneeberger, in his individual capacity